ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Inhalers Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Othe-3U267
Home | Market Reports | Health| Medical Devices & Equipment
Global Respiratory Inhalers Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Respiratory Inhalers Market Insights, Forecast to 2029

Code: QYRE-Othe-3U267
Report
August 2023
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Adherium
Astrazeneca plc
Boehringer Ingelheim GmbH
Chiesi Farmaceutici
GSK
Propeller Health
Teva Pharmaceutical Industries Ltd

Respiratory Inhalers Market Size

The global Respiratory Inhalers market is projected to grow from US$ 29220 million in 2023 to US$ 31670 million by 2029, at a Compound Annual Growth Rate (CAGR) of 1.3% during the forecast period.

Respiratory Inhalers Market

Respiratory Inhalers Market

Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients.
Market Analysis and Insights: Global Respiratory Inhalers Market
Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market. This large share is majorly due to, tobacco smoke which is a key factor in the development and progression of COPD. COPD was considered the third leading cause of death in U.S. in 2017, with almost 6% of Americans diagnosed with the disease.
Report Includes
This report presents an overview of global market for Respiratory Inhalers market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Respiratory Inhalers, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Respiratory Inhalers, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Respiratory Inhalers revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Respiratory Inhalers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Respiratory Inhalers revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc., Propeller Health and Teva Pharmaceutical Industries Ltd., etc.

Scope of Respiratory Inhalers Market Report

Report Metric Details
Report Name Respiratory Inhalers Market
Accounted market size in 2023 US$ 29220 million
Forecasted market size in 2029 US$ 31670 million
CAGR 1.3
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Dry Powder Inhaler
  • Metered Dose Inhaler
  • Others
Segment by Application
  • Asthma
  • COPD
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc., Propeller Health, Teva Pharmaceutical Industries Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Respiratory Inhalers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Respiratory Inhalers companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Inhalers revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Respiratory Inhalers Market growing?

Ans: The Respiratory Inhalers Market witnessing a CAGR of 1.3 during the forecast period 2023-2029.

What is the Respiratory Inhalers Market size in 2029?

Ans: The global Respiratory Inhalers market is projected to grow from US$ 29220 million in 2023 to US$ 31670 million by 2029, at a Compound Annual Growth Rate (CAGR) of 1.3% during the forecast period.

What is the Respiratory Inhalers Market share by region?

Ans: Globally North America is the largest market for Respiratory Inhalers accounting 35.1% of the total market.

What is the Respiratory Inhalers Market share by application?

Ans: COPD was considered the third leading cause of death in U.S. in 2017, with almost 6% of Americans diagnosed with the disease.

Who are the main players in the Respiratory Inhalers Market report?

Ans: The main players in the Respiratory Inhalers Market are Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc., Propeller Health, Teva Pharmaceutical Industries Ltd.

What are the Application segmentation covered in the Respiratory Inhalers Market report?

Ans: The Applications covered in the Respiratory Inhalers Market report are Asthma, COPD, Other

What are the Type segmentation covered in the Respiratory Inhalers Market report?

Ans: The Types covered in the Respiratory Inhalers Market report are Dry Powder Inhaler, Metered Dose Inhaler, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Inhalers Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Dry Powder Inhaler
1.2.3 Metered Dose Inhaler
1.2.4 Others
1.3 Market by Application
1.3.1 Global Respiratory Inhalers Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Asthma
1.3.3 COPD
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Inhalers Market Perspective (2018-2029)
2.2 Global Respiratory Inhalers Growth Trends by Region
2.2.1 Respiratory Inhalers Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Respiratory Inhalers Historic Market Size by Region (2018-2023)
2.2.3 Respiratory Inhalers Forecasted Market Size by Region (2024-2029)
2.3 Respiratory Inhalers Market Dynamics
2.3.1 Respiratory Inhalers Industry Trends
2.3.2 Respiratory Inhalers Market Drivers
2.3.3 Respiratory Inhalers Market Challenges
2.3.4 Respiratory Inhalers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Respiratory Inhalers by Players
3.1.1 Global Respiratory Inhalers Revenue by Players (2018-2023)
3.1.2 Global Respiratory Inhalers Revenue Market Share by Players (2018-2023)
3.2 Global Respiratory Inhalers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Respiratory Inhalers, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Respiratory Inhalers Market Concentration Ratio
3.4.1 Global Respiratory Inhalers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Inhalers Revenue in 2022
3.5 Global Key Players of Respiratory Inhalers Head office and Area Served
3.6 Global Key Players of Respiratory Inhalers, Product and Application
3.7 Global Key Players of Respiratory Inhalers, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Inhalers Breakdown Data by Type
4.1 Global Respiratory Inhalers Historic Market Size by Type (2018-2023)
4.2 Global Respiratory Inhalers Forecasted Market Size by Type (2024-2029)
5 Respiratory Inhalers Breakdown Data by Application
5.1 Global Respiratory Inhalers Historic Market Size by Application (2018-2023)
5.2 Global Respiratory Inhalers Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Respiratory Inhalers Market Size (2018-2029)
6.2 North America Respiratory Inhalers Market Size by Type
6.2.1 North America Respiratory Inhalers Market Size by Type (2018-2023)
6.2.2 North America Respiratory Inhalers Market Size by Type (2024-2029)
6.2.3 North America Respiratory Inhalers Market Share by Type (2018-2029)
6.3 North America Respiratory Inhalers Market Size by Application
6.3.1 North America Respiratory Inhalers Market Size by Application (2018-2023)
6.3.2 North America Respiratory Inhalers Market Size by Application (2024-2029)
6.3.3 North America Respiratory Inhalers Market Share by Application (2018-2029)
6.4 North America Respiratory Inhalers Market Size by Country
6.4.1 North America Respiratory Inhalers Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Respiratory Inhalers Market Size by Country (2018-2023)
6.4.3 North America Respiratory Inhalers Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Respiratory Inhalers Market Size (2018-2029)
7.2 Europe Respiratory Inhalers Market Size by Type
7.2.1 Europe Respiratory Inhalers Market Size by Type (2018-2023)
7.2.2 Europe Respiratory Inhalers Market Size by Type (2024-2029)
7.2.3 Europe Respiratory Inhalers Market Share by Type (2018-2029)
7.3 Europe Respiratory Inhalers Market Size by Application
7.3.1 Europe Respiratory Inhalers Market Size by Application (2018-2023)
7.3.2 Europe Respiratory Inhalers Market Size by Application (2024-2029)
7.3.3 Europe Respiratory Inhalers Market Share by Application (2018-2029)
7.4 Europe Respiratory Inhalers Market Size by Country
7.4.1 Europe Respiratory Inhalers Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Respiratory Inhalers Market Size by Country (2018-2023)
7.4.3 Europe Respiratory Inhalers Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Respiratory Inhalers Market Size (2018-2029)
8.2 China Respiratory Inhalers Market Size by Type
8.2.1 China Respiratory Inhalers Market Size by Type (2018-2023)
8.2.2 China Respiratory Inhalers Market Size by Type (2024-2029)
8.2.3 China Respiratory Inhalers Market Share by Type (2018-2029)
8.3 China Respiratory Inhalers Market Size by Application
8.3.1 China Respiratory Inhalers Market Size by Application (2018-2023)
8.3.2 China Respiratory Inhalers Market Size by Application (2024-2029)
8.3.3 China Respiratory Inhalers Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Respiratory Inhalers Market Size (2018-2029)
9.2 Asia Respiratory Inhalers Market Size by Type
9.2.1 Asia Respiratory Inhalers Market Size by Type (2018-2023)
9.2.2 Asia Respiratory Inhalers Market Size by Type (2024-2029)
9.2.3 Asia Respiratory Inhalers Market Share by Type (2018-2029)
9.3 Asia Respiratory Inhalers Market Size by Application
9.3.1 Asia Respiratory Inhalers Market Size by Application (2018-2023)
9.3.2 Asia Respiratory Inhalers Market Size by Application (2024-2029)
9.3.3 Asia Respiratory Inhalers Market Share by Application (2018-2029)
9.4 Asia Respiratory Inhalers Market Size by Region
9.4.1 Asia Respiratory Inhalers Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Respiratory Inhalers Market Size by Region (2018-2023)
9.4.3 Asia Respiratory Inhalers Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Respiratory Inhalers Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Type
10.2.1 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Respiratory Inhalers Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Application
10.3.1 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Respiratory Inhalers Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Country
10.4.1 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Adherium limited
11.1.1 Adherium limited Company Details
11.1.2 Adherium limited Business Overview
11.1.3 Adherium limited Respiratory Inhalers Introduction
11.1.4 Adherium limited Revenue in Respiratory Inhalers Business (2018-2023)
11.1.5 Adherium limited Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Respiratory Inhalers Introduction
11.2.4 AstraZeneca Revenue in Respiratory Inhalers Business (2018-2023)
11.2.5 AstraZeneca Recent Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Respiratory Inhalers Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Respiratory Inhalers Business (2018-2023)
11.3.5 Boehringer Ingelheim GmbH Recent Developments
11.4 Chiesi Farmaceutici S.p.A.
11.4.1 Chiesi Farmaceutici S.p.A. Company Details
11.4.2 Chiesi Farmaceutici S.p.A. Business Overview
11.4.3 Chiesi Farmaceutici S.p.A. Respiratory Inhalers Introduction
11.4.4 Chiesi Farmaceutici S.p.A. Revenue in Respiratory Inhalers Business (2018-2023)
11.4.5 Chiesi Farmaceutici S.p.A. Recent Developments
11.5 GSK plc.
11.5.1 GSK plc. Company Details
11.5.2 GSK plc. Business Overview
11.5.3 GSK plc. Respiratory Inhalers Introduction
11.5.4 GSK plc. Revenue in Respiratory Inhalers Business (2018-2023)
11.5.5 GSK plc. Recent Developments
11.6 Propeller Health
11.6.1 Propeller Health Company Details
11.6.2 Propeller Health Business Overview
11.6.3 Propeller Health Respiratory Inhalers Introduction
11.6.4 Propeller Health Revenue in Respiratory Inhalers Business (2018-2023)
11.6.5 Propeller Health Recent Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Details
11.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.7.3 Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Introduction
11.7.4 Teva Pharmaceutical Industries Ltd. Revenue in Respiratory Inhalers Business (2018-2023)
11.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Adherium
Astrazeneca plc
Boehringer Ingelheim GmbH
Chiesi Farmaceutici
GSK
Propeller Health
Teva Pharmaceutical Industries Ltd
List of Tables
    Table 1. Global Respiratory Inhalers Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Dry Powder Inhaler
    Table 3. Key Players of Metered Dose Inhaler
    Table 4. Key Players of Others
    Table 5. Global Respiratory Inhalers Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 6. Global Respiratory Inhalers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Respiratory Inhalers Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Respiratory Inhalers Market Share by Region (2018-2023)
    Table 9. Global Respiratory Inhalers Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Respiratory Inhalers Market Share by Region (2024-2029)
    Table 11. Respiratory Inhalers Market Trends
    Table 12. Respiratory Inhalers Market Drivers
    Table 13. Respiratory Inhalers Market Challenges
    Table 14. Respiratory Inhalers Market Restraints
    Table 15. Global Respiratory Inhalers Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Respiratory Inhalers Revenue Share by Players (2018-2023)
    Table 17. Global Top Respiratory Inhalers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Inhalers as of 2022)
    Table 18. Global Respiratory Inhalers Industry Ranking 2021 VS 2022 VS 2023
    Table 19. Global 5 Largest Players Market Share by Respiratory Inhalers Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Global Key Players of Respiratory Inhalers, Headquarters and Area Served
    Table 21. Global Key Players of Respiratory Inhalers, Product and Application
    Table 22. Global Key Players of Respiratory Inhalers, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Respiratory Inhalers Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Respiratory Inhalers Revenue Market Share by Type (2018-2023)
    Table 26. Global Respiratory Inhalers Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Respiratory Inhalers Revenue Market Share by Type (2024-2029)
    Table 28. Global Respiratory Inhalers Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Respiratory Inhalers Revenue Share by Application (2018-2023)
    Table 30. Global Respiratory Inhalers Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Respiratory Inhalers Revenue Share by Application (2024-2029)
    Table 32. North America Respiratory Inhalers Market Size by Type (2018-2023) & (US$ Million)
    Table 33. North America Respiratory Inhalers Market Size by Type (2024-2029) & (US$ Million)
    Table 34. North America Respiratory Inhalers Market Size by Application (2018-2023) & (US$ Million)
    Table 35. North America Respiratory Inhalers Market Size by Application (2024-2029) & (US$ Million)
    Table 36. North America Respiratory Inhalers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. North America Respiratory Inhalers Market Size by Country (2018-2023) & (US$ Million)
    Table 38. North America Respiratory Inhalers Market Size by Country (2024-2029) & (US$ Million)
    Table 39. Europe Respiratory Inhalers Market Size by Type (2018-2023) & (US$ Million)
    Table 40. Europe Respiratory Inhalers Market Size by Type (2024-2029) & (US$ Million)
    Table 41. Europe Respiratory Inhalers Market Size by Application (2018-2023) & (US$ Million)
    Table 42. Europe Respiratory Inhalers Market Size by Application (2024-2029) & (US$ Million)
    Table 43. Europe Respiratory Inhalers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Europe Respiratory Inhalers Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Europe Respiratory Inhalers Market Size by Country (2024-2029) & (US$ Million)
    Table 46. China Respiratory Inhalers Market Size by Type (2018-2023) & (US$ Million)
    Table 47. China Respiratory Inhalers Market Size by Type (2024-2029) & (US$ Million)
    Table 48. China Respiratory Inhalers Market Size by Application (2018-2023) & (US$ Million)
    Table 49. China Respiratory Inhalers Market Size by Application (2024-2029) & (US$ Million)
    Table 50. Asia Respiratory Inhalers Market Size by Type (2018-2023) & (US$ Million)
    Table 51. Asia Respiratory Inhalers Market Size by Type (2024-2029) & (US$ Million)
    Table 52. Asia Respiratory Inhalers Market Size by Application (2018-2023) & (US$ Million)
    Table 53. Asia Respiratory Inhalers Market Size by Application (2024-2029) & (US$ Million)
    Table 54. Asia Respiratory Inhalers Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 55. Asia Respiratory Inhalers Market Size by Region (2018-2023) & (US$ Million)
    Table 56. Asia Respiratory Inhalers Market Size by Region (2024-2029) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Type (2018-2023) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Type (2024-2029) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Application (2018-2023) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Application (2024-2029) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Respiratory Inhalers Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 62. Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Country (2018-2023) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Respiratory Inhalers Market Size by Country (2024-2029) & (US$ Million)
    Table 64. Adherium limited Company Details
    Table 65. Adherium limited Business Overview
    Table 66. Adherium limited Respiratory Inhalers Product
    Table 67. Adherium limited Revenue in Respiratory Inhalers Business (2018-2023) & (US$ Million)
    Table 68. Adherium limited Recent Developments
    Table 69. AstraZeneca Company Details
    Table 70. AstraZeneca Business Overview
    Table 71. AstraZeneca Respiratory Inhalers Product
    Table 72. AstraZeneca Revenue in Respiratory Inhalers Business (2018-2023) & (US$ Million)
    Table 73. AstraZeneca Recent Developments
    Table 74. Boehringer Ingelheim GmbH Company Details
    Table 75. Boehringer Ingelheim GmbH Business Overview
    Table 76. Boehringer Ingelheim GmbH Respiratory Inhalers Product
    Table 77. Boehringer Ingelheim GmbH Revenue in Respiratory Inhalers Business (2018-2023) & (US$ Million)
    Table 78. Boehringer Ingelheim GmbH Recent Developments
    Table 79. Chiesi Farmaceutici S.p.A. Company Details
    Table 80. Chiesi Farmaceutici S.p.A. Business Overview
    Table 81. Chiesi Farmaceutici S.p.A. Respiratory Inhalers Product
    Table 82. Chiesi Farmaceutici S.p.A. Revenue in Respiratory Inhalers Business (2018-2023) & (US$ Million)
    Table 83. Chiesi Farmaceutici S.p.A. Recent Developments
    Table 84. GSK plc. Company Details
    Table 85. GSK plc. Business Overview
    Table 86. GSK plc. Respiratory Inhalers Product
    Table 87. GSK plc. Revenue in Respiratory Inhalers Business (2018-2023) & (US$ Million)
    Table 88. GSK plc. Recent Developments
    Table 89. Propeller Health Company Details
    Table 90. Propeller Health Business Overview
    Table 91. Propeller Health Respiratory Inhalers Product
    Table 92. Propeller Health Revenue in Respiratory Inhalers Business (2018-2023) & (US$ Million)
    Table 93. Propeller Health Recent Developments
    Table 94. Teva Pharmaceutical Industries Ltd. Company Details
    Table 95. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 96. Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Product
    Table 97. Teva Pharmaceutical Industries Ltd. Revenue in Respiratory Inhalers Business (2018-2023) & (US$ Million)
    Table 98. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Respiratory Inhalers Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Respiratory Inhalers Market Share by Type: 2022 VS 2029
    Figure 3. Dry Powder Inhaler Features
    Figure 4. Metered Dose Inhaler Features
    Figure 5. Others Features
    Figure 6. Global Respiratory Inhalers Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 7. Global Respiratory Inhalers Market Share by Application: 2022 VS 2029
    Figure 8. Asthma Case Studies
    Figure 9. COPD Case Studies
    Figure 10. Other Case Studies
    Figure 11. Respiratory Inhalers Report Years Considered
    Figure 12. Global Respiratory Inhalers Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Respiratory Inhalers Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Respiratory Inhalers Market Share by Region: 2022 VS 2029
    Figure 15. Global Respiratory Inhalers Market Share by Players in 2022
    Figure 16. Global Top Respiratory Inhalers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Inhalers as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Respiratory Inhalers Revenue in 2022
    Figure 18. North America Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Respiratory Inhalers Market Share by Type (2018-2029)
    Figure 20. North America Respiratory Inhalers Market Share by Application (2018-2029)
    Figure 21. North America Respiratory Inhalers Market Share by Country (2018-2029)
    Figure 22. United States Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Respiratory Inhalers Market Size YoY (2018-2029) & (US$ Million)
    Figure 25. Europe Respiratory Inhalers Market Share by Type (2018-2029)
    Figure 26. Europe Respiratory Inhalers Market Share by Application (2018-2029)
    Figure 27. Europe Respiratory Inhalers Market Share by Country (2018-2029)
    Figure 28. Germany Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. France Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. U.K. Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Italy Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Russia Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Nordic Countries Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. China Respiratory Inhalers Market Size YoY (2018-2029) & (US$ Million)
    Figure 35. China Respiratory Inhalers Market Share by Type (2018-2029)
    Figure 36. China Respiratory Inhalers Market Share by Application (2018-2029)
    Figure 37. Asia Respiratory Inhalers Market Size YoY (2018-2029) & (US$ Million)
    Figure 38. Asia Respiratory Inhalers Market Share by Type (2018-2029)
    Figure 39. Asia Respiratory Inhalers Market Share by Application (2018-2029)
    Figure 40. Asia Respiratory Inhalers Market Share by Region (2018-2029)
    Figure 41. Japan Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. South Korea Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. China Taiwan Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. India Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Australia Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Respiratory Inhalers Market Size YoY (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Respiratory Inhalers Market Share by Type (2018-2029)
    Figure 49. Middle East, Africa, and Latin America Respiratory Inhalers Market Share by Application (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Respiratory Inhalers Market Share by Country (2018-2029)
    Figure 51. Brazil Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Mexico Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Turkey Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Israel Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. GCC Countries Respiratory Inhalers Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Adherium limited Revenue Growth Rate in Respiratory Inhalers Business (2018-2023)
    Figure 58. AstraZeneca Revenue Growth Rate in Respiratory Inhalers Business (2018-2023)
    Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Respiratory Inhalers Business (2018-2023)
    Figure 60. Chiesi Farmaceutici S.p.A. Revenue Growth Rate in Respiratory Inhalers Business (2018-2023)
    Figure 61. GSK plc. Revenue Growth Rate in Respiratory Inhalers Business (2018-2023)
    Figure 62. Propeller Health Revenue Growth Rate in Respiratory Inhalers Business (2018-2023)
    Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Respiratory Inhalers Business (2018-2023)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions